AbbVie’s Humira tops ICER’s list of unwarranted price hikes againWith drug pricing controls back on the legislative table in the US, the influential Institute for Clinical and Share XAbbVie’s Humira tops ICER’s list of unwarranted price hikes againhttps://pharmaphorum.com/news/abbvies-humira-tops-icers-list-of-unwarranted-price-hikes-again/
Democrats agree last-ditch deal to save drug pricing plansUnder fire for abandoning a plan to allow Medicare to negotiate drug pricing, Democrats in the Senate have Share XDemocrats agree last-ditch deal to save drug pricing planshttps://pharmaphorum.com/news/democrats-agree-last-ditch-deal-to-save-drug-pricing-plans/
COVID jabs much more effective than virus at preventing infectionA US study has found that the immunity afforded by COVID-19 vaccines is much stronger than that stimulated Share XCOVID jabs much more effective than virus at preventing infectionhttps://pharmaphorum.com/news/covid-jabs-much-more-effective-than-virus-at-preventing-infection/
White House backtracks on medicine price control plansPresident Joe Biden has jettisoned a raft of policy proposals aimed at curbing the price of prescription medicines Share XWhite House backtracks on medicine price control planshttps://pharmaphorum.com/news/white-house-backtracks-on-medicine-price-control-plans/
Biogen admits slow Aduhelm launch, as scientists question label againShares in Biogen have come under pressure after chief executive Michel Vounatsos admitted that the company is facing Share XBiogen admits slow Aduhelm launch, as scientists question label againhttps://pharmaphorum.com/news/biogen-admits-slow-aduhelm-launch-as-scientists-question-label-again/
FTC drops AbbVie antitrust case, but fires a parting shot at the firmAbbVie will not be pursued any further by the US government over allegations that it used ‘sham’ litigation Share XFTC drops AbbVie antitrust case, but fires a parting shot at the firmhttps://pharmaphorum.com/news/ftc-drops-abbvie-antitrust-case-but-fires-a-parting-shot-at-the-firm/
FDA okays Viatris’ insulin drug as first ‘interchangeable’ biosimilarGeneric drugmaker Viatris has become the first company to secure FDA approval for a biosimilar product that is Share XFDA okays Viatris’ insulin drug as first ‘interchangeable’ biosimilarhttps://pharmaphorum.com/news/fda-okays-mylan-insulin-drug-as-first-interchangeable-biosimilar/
White House pledges $3 billion war chest for COVID antiviralsThe Biden Administration has said it will allocate $3 billion of its pandemic rescue plan to the development Share XWhite House pledges $3 billion war chest for COVID antiviralshttps://pharmaphorum.com/news/white-house-pledges-3-billion-war-chest-for-covid-antivirals/
US orders 500m Pfizer/BioNTech COVID jabs for developing nationsThe US government will buy 500 million more doses of the Pfizer/BioNTech COVID-19 vaccine that will be given Share XUS orders 500m Pfizer/BioNTech COVID jabs for developing nationshttps://pharmaphorum.com/news/us-orders-500m-pfizer-biontech/
